FOXO3A regulation by miRNA-29a controls chondrogenic differentiation of mesenchymal stem cells and cartilage formation

Stem Cells and Development

Volumn 23, Issue 11, 2014, Pages 1195-1205

  Guérit, David ^a,b   Brondello, Jean Marc ^a,b   Chuchana, Paul ^a,b   Philipot, Didier ^a,b   Toupet, Karine ^a,b   Bony, Claire ^a,b   Jorgensen, Christian ^a,b,c   Noël, Danièle ^a,b  

^a HÔPITAL SAINT ELOI   (France)

^b UNIV MONTPELLIER   (France)

^c LAPEYRONIE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTAGOMIR; MICRORNA 29A; OLIGONUCLEOTIDE; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR FKHRL1; TRANSCRIPTION FACTOR SOX9; TRANSCRIPTION FACTOR YY1; FORKHEAD TRANSCRIPTION FACTOR; FOXO3 PROTEIN, HUMAN; MICRORNA; MIRN29 MICRORNA, HUMAN;

ANIMAL CELL; ARTICLE; CARTILAGE; CARTILAGE CELL; CELL DIFFERENTIATION; CHONDROGENESIS; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; IN VIVO STUDY; MESENCHYMAL STEM CELL; MOUSE; NONHUMAN; OSSIFICATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TISSUE REGENERATION; TRANSCRIPTION REGULATION; TRANSCRIPTOMICS; UPREGULATION; ANIMAL; BONE DEVELOPMENT; CELL CULTURE; GENE EXPRESSION REGULATION; GENETICS; MESENCHYMAL STROMA CELL; PHYSIOLOGY;

ANIMALS; CARTILAGE; CELL DIFFERENTIATION; CELLS, CULTURED; CHONDROCYTES; CHONDROGENESIS; FORKHEAD TRANSCRIPTION FACTORS; GENE EXPRESSION REGULATION; HUMANS; MESENCHYMAL STROMAL CELLS; MICE; MICRORNAS; OSTEOGENESIS;

EID: 84901317768     PISSN: 15473287     EISSN: 15578534     Source Type: Journal    
DOI: 10.1089/scd.2013.0463     Document Type: Article

References (43)

1. Goldring MB, K Tsuchimochi and K Ijiri. (2006). The control of chondrogenesis. J Cell Biochem 97:33-44.
2. Lefebvre V and P Smits. (2005). Transcriptional control of chondrocyte fate and differentiation. Birth Defects Res C Embryo Today 75:200-212.
3. Heinrich EM and S Dimmeler. (2012). MicroRNAs and stem cells: control of pluripotency, reprogramming, and lineage commitment. Circ Res 110:1014-1022.
4. Kobayashi T, J Lu, BS Cobb, SJ Rodda, AP McMahon, E Schipani, M Merkenschlager and HM Kronenberg. (2008). Dicer-dependent pathways regulate chondrocyte proliferation and differentiation. Proc Natl Acad Sci U S A 105: 1949-1954.
5. Hong E and AH Reddi. (2012). MicroRNAs in chondrogenesis, articular cartilage and osteoarthritis: implications for tissue engineering. Tissue Eng Part B Rev 18: 445-453.
6. Goldring MB and KB Marcu. (2012). Epigenomic and microRNA-mediated regulation in cartilage development, homeostasis, and osteoarthritis. Trends Mol Med 18: 109-118.
7. Miyaki S, T Nakasa, S Otsuki, SP Grogan, R Higashiyama, A Inoue, Y Kato, T Sato, MK Lotz and H Asahara. (2009). MicroRNA-140 is expressed in differentiated human articular chondrocytes and modulates interleukin-1 responses. Arthritis Rheum 60:2723-2730.
8. Miyaki S, T Sato, A Inoue, S Otsuki, Y Ito, S Yokoyama, Y Kato, F Takemoto, T Nakasa, et al. (2010). MicroRNA-140 plays dual roles in both cartilage development and homeostasis. Genes Dev 24:1173-1185.
9. Lin EA, L Kong, XH Bai, Y Luan and CJ Liu. (2009). miR-199a, a bone morphogenic protein 2-responsive MicroRNA, regulates chondrogenesis via direct targeting to Smad1. J Biol Chem 284:11326-11335.
10. Yang B, H Guo, Y Zhang, L Chen, D Ying and S Dong. (2011). MicroRNA-145 regulates chondrogenic differentiation of mesenchymal stem cells by targeting Sox9. PLoS One 6:e21679.
11. Xu J, Y Kang, WM Liao and L Yu. (2012). MiR-194 regulates chondrogenic differentiation of human adiposederived stem cells by targeting Sox5. PLoS One 7:e31861.
12. Kapinas K, C Kessler, T Ricks, G Gronowicz and AM Delany. (2010). miR-29 modulates Wnt signaling in human osteoblasts through a positive feedback loop. J Biol Chem 285:25221-25231.
13. Li Z, MQ Hassan, M Jafferji, RI Aqeilan, R Garzon, CM Croce, AJ van Wijnen, JL Stein, GS Stein and JB Lian. (2009). Biological functions of miR-29b contribute to positive regulation of osteoblast differentiation. J Biol Chem 284:15676-15684.
14. Kapinas K, CB Kessler and AM Delany. (2009). miR-29 suppression of osteonectin in osteoblasts: regulation during differentiation and by canonical Wnt signaling. J Cell Biochem 108:216-224.
15. Winbanks CE, B Wang, C Beyer, P Koh, L White, P Kantharidis and P Gregorevic. (2011). TGF-beta regulates miR-206 and miR-29 to control myogenic differentiation through regulation of HDAC4. J Biol Chem 286:13805-13814.
16. Zhou L, L Wang, L Lu, P Jiang, H Sun and H Wang. (2012). A Novel Target of microRNA-29, Ring1 and YY1 Binding Protein (Rybp), Negatively Regulates Skeletal Myogenesis. J Biol Chem 287:25255-25265.
17. Zhou L, L Wang, L Lu, P Jiang, H Sun and H Wang. (2012). Inhibition of miR-29 by TGF-beta-Smad3 signaling through dual mechanisms promotes transdifferentiation of mouse myoblasts into myofibroblasts. PLoS One 7:e33766.
18. Djouad F, C Bony, T Haupl, G Uze, N Lahlou, P Louis- Plence, F Apparailly, F Canovas, T Reme, et al. (2005). Transcriptional profiles discriminate bone marrow-derived and synovium-derived mesenchymal stem cells. Arthritis Res Ther 7:R1304-R1315.
19. Mrugala D, N Dossat, J Ringe, B Delorme, A Coffy, C Bony, P Charbord, T Haupl, JP Daures, D Noel and C Jorgensen. (2009). Gene expression profile of multipotent mesenchymal stromal cells: identification of pathways common to TGFbeta3/BMP2-induced chondrogenesis. Cloning Stem Cells 11:61-76.
20. Finger F, C Schorle, S Soder, A Zien, MB Goldring and T Aigner. (2004). Phenotypic characterization of human chondrocyte cell line C-20/A4: a comparison between monolayer and alginate suspension culture. Cells Tissues Organs 178:65-77.
21. Chuchana P, D Marchand, M Nugoli, C Rodriguez, N Molinari and JA Garcia-Sanz. (2007). An adaptation of the LMS method to determine expression variations in profiling data. Nucleic Acids Res 35:e71.
22. Shi R and VL Chiang. (2005). Facile means for quantifying microRNA expression by real-time PCR. Biotechniques 39:519-525.
23. De Santa Barbara P, N Bonneaud, B Boizet, M Desclozeaux, B Moniot, P Sudbeck, G Scherer, F Poulat and P Berta. (1998). Direct interaction of SRY-related protein SOX9 and steroidogenic factor 1 regulates transcription of the human anti-Mullerian hormone gene. Mol Cell Biol 18:6653-6665.
24. Wang H, E Hertlein, N Bakkar, H Sun, S Acharyya, J Wang, M Carathers, R Davuluri and DC Guttridge. (2007). NF-kappaB regulation of YY1 inhibits skeletal myogenesis through transcriptional silencing of myofibrillar genes. Mol Cell Biol 27:4374-4387.
25. Brons PP, AH Pennings, C Haanen, HM Wessels and JB Boezeman. (1990). Simultaneous measurement of DNA content and cell-surface immunofluorescence of human bone marrow cells using a single laser flow cytometer. Cytometry 11:837-844.
26. Lefebvre V, RR Behringer and B de Crombrugghe. (2001). L-Sox5, Sox6 and Sox9 control essential steps of the chondrocyte differentiation pathway. Osteoarthritis Cartilage 9 Suppl A:S69-S75.
27. Le Bechec A, E Portales-Casamar, G Vetter, M Moes, PJ Zindy, ASaumet, DArenillas, CTheillet, WWWasserman, CH Lecellier and E Friederich. (2011). MIR@NT@N: a framework integrating transcription factors, microRNAs and their targets to identify sub-network motifs in a meta-regulation network model. BMC Bioinformatics 12:67.
28. Aoyama T, T Okamoto, K Fukiage, S Otsuka, M Furu, K Ito, Y Jin, M Ueda, S Nagayama, et al. (2010). Histone modifiers, YY1 and p300, regulate the expression of cartilage- specific gene, chondromodulin-I, in mesenchymal stem cells. J Biol Chem 285:29842-29850.
29. Shin I, AV Bakin, U Rodeck, A Brunet and CL Arteaga. (2001). Transforming growth factor beta enhances epithelial cell survival via Akt-dependent regulation of FKHRL1. Mol Biol Cell 12:3328-3339.
30. Djouad F, C Bony, F Canovas, O Fromigue, T Reme, C Jorgensen and D Noel. (2009). Transcriptomic analysis identifies Foxo3A as a novel transcription factor regulating mesenchymal stem cell chrondrogenic differentiation. Cloning Stem Cells 11:407-416.
31. Salih DA and A Brunet. (2008). FoxO transcription factors in the maintenance of cellular homeostasis during aging. Curr Opin Cell Biol 20:126-136.
32. Kriegel AJ, Y Liu, Y Fang, X Ding andMLiang. (2012). The miR-29 family: genomics, cell biology, and relevance to renal and cardiovascular injury. Physiol Genomics 44:237-244.
33. Smith KM, M Guerau-de-Arellano, S Costinean, JL Williams, A Bottoni, G Mavrikis Cox, AR Satoskar, CM Croce, MK Racke, AE Lovett-Racke and CC Whitacre. (2012). miR-29ab1 deficiency identifies a negative feedback loop controlling Th1 bias that is dysregulated in multiple sclerosis. J Immunol 189:1567-1576.
34. Eyholzer M, S Schmid, L Wilkens, BU Mueller and T Pabst. (2010). The tumour-suppressive miR-29a/b1 cluster is regulated by CEBPA and blocked in human AML. Br J Cancer 103:275-284.
35. Yukata K, Y Matsui, C Shukunami, A Takimoto, T Goto, Y Nishizaki, Y Nakamichi, T Kubo, T Sano, et al. (2008). Altered fracture callus formation in chondromodulin-I deficient mice. Bone 43:1047-1056.
36. Liu Y, NE Taylor, L Lu, K Usa, AW Cowley Jr., NR Ferreri, NC Yeo and M Liang. (2010). Renal medullary microRNAs in Dahl salt-sensitive rats: miR-29b regulates several collagens and related genes. Hypertension 55: 974-982.
37. Day TF, X Guo, L Garrett-Beal and Y Yang. (2005). Wnt/ beta-catenin signaling in mesenchymal progenitors controls osteoblast and chondrocyte differentiation during vertebrate skeletogenesis. Dev Cell 8:739-750.
38. ArnoldMA, Y Kim, MP Czubryt, D Phan, J McAnally, X Qi, JM Shelton, JA Richardson, R Bassel-Duby and EN Olson. (2007). MEF2C transcription factor controls chondrocyte hypertrophy and bone development. Dev Cell 12:377-389.
39. Vega RB, K Matsuda, J Oh, AC Barbosa, X Yang, E Meadows, J McAnally, C Pomajzl, JM Shelton, et al. (2004). Histone deacetylase 4 controls chondrocyte hypertrophy during skeletogenesis. Cell 119:555-566.
40. Pei M, D Chen, J Li and L Wei. (2009). Histone deacetylase 4 promotes TGF-beta1-induced synovium-derived stem cell chondrogenesis but inhibits chondrogenically differentiated stem cell hypertrophy. Differentiation 78: 260-268.
41. Ambrogini E, M Almeida, M Martin-Millan, JH Paik, RA Depinho, L Han, J Goellner, RS Weinstein, RL Jilka, CA O'Brien and SC Manolagas. (2010). FoxO-mediated defense against oxidative stress in osteoblasts is indispensable for skeletal homeostasis in mice. Cell Metab 11:136-146.
42. Rokutanda S, T Fujita, N Kanatani, CA Yoshida, H Komori, W Liu, A Mizuno and T Komori. (2009). Akt regulates skeletal development through GSK3, mTOR, and FoxOs. Dev Biol 328:78-93.
43. Ikegami D, H Akiyama, A Suzuki, T Nakamura, T Nakano, H Yoshikawa and N Tsumaki. (2011). Sox9 sustains chondrocyte survival and hypertrophy in part through Pik3ca-Akt pathways. Development 138:1507-1519.